Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Shattuck Labs Inc
STTK | US
1.25
USD-0.10
-7.41%
STTK | US
About Shattuck Labs Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
21/10/2024
Close
1.25
Open
1.37
High
1.39
Low
1.25
Shattuck Labs Inc. a clinical-stage biotechnology company develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154 which is in Phase 1 clinical trial for the treatment of ovarian fallopian tube and peritoneal cancers. The company was incorporated in 2016 and is headquartered in Austin Texas.
View LessSTTK | US
Risk
215.4
Sharpe
-0.15
Luna's Score
42/100
Recommendation
Sell
Luna says (STTK | US)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
What's not Working
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
High Short percentage (> 15%)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
108.6%1 month
215.4%3 months
134.5%6 months
113.7%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.60
Debt to equity
0.03
Debt to assets
0.03
Ent. to EBITDA
-3.62
Ent. to rev.
18.32
PEG
-
Other Fundamentals
EBITDA
-86.32M
MarketCap
59.66M
MarketCap(USD)
59.66M
Div. yield
-
Op. margin
-1.43K
Erngs. growth
-
Rev. growth
704.50
Ret. on equity
-68.48
Short ratio
37.02
Short perc.
17.17
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.60
Range1M
2.88
Range3M
3.54
Volumes: Market Activity
Rel. volume
0.34
Price X volume
563.14K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -3.62 | - | Cheaper |
| Ent. to Revenue | 18.32 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 0.60 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 134.46 | - | Riskier |
| Debt to Equity | 0.03 | -1.23 | Expensive |
| Debt to Assets | 0.03 | 0.25 | Cheaper |
| Market Cap | 59.66M | - | Emerging |
